From: Dose-dense adjuvant chemotherapy for primary breast cancer
Comparison (n) | Recurrence | Death |
---|---|---|
CMF versus nil (8150) | +24 ± 3 | +14 ± 4 |
CMF+ versus nil (3218) | +20 ± 5 | +15 ± 5 |
Anthracyclines+ versus CMF (6950) | +12 ± 4 | +11 ± 5 |
Longer versus shorter (6104) | +7 ± 4 | -1 ± 5 |